Lionel Breton got a PhD in 1982 in general endocrinology in the lab of R. Mi­chel and J. Roche at College de France in Paris. Then in 1985, he got a state doctorate in general pharmacology at the Poitiers University Hospital. After eight years as a project leader in neuropharmacology at Servier Laboratory, Lionel joined L’Oreal corporate 26 years ago. He is also a visiting professor/ affiliate member at the prestigious McGill University in Montreal, Canada. He is an expert on neurobiology and physiology, skin neuroimmunology, skin and gut microbiology and of some aspects of translational research. He is cur­rently scientific director at L’Oreal Research. Lionel is a co-inventor of many national patents and applications and of breakthroughs at L’Oreal corporate. Although industrial, he has published more than 80 papers in peer-reviewed journals and is frequently invited to give plenary sessions or keynotes.

Dr. Jay Tiesman is a Research Fellow in the global bioscience division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the genomics group leader and, since joining P&G in 1993, has been actively involved in developing genomics and metagenomics capabilities within the company. He has been particularly interested in the use of these platforms to gain insight into epithelial cell biology. Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodel­ling. He obtained his PhD in pathology from the University of Nebraska Medi­cal Center in Omaha, Nebraska. In Omaha, he worked in the laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained bachelor’s degrees in philosophy and biology at Creighton Univer­sity in Omaha. Jay is an acknowledged expert in genomics and microbiome experimental design and has published over 50 articles and book chapters, two of which have earned “Publication of the Year” honours and one of which earned recognition from the Faculty of 1000. He also speaks exten­sively at international meetings on the topic of transcriptomics experimental design and is listed on over 130 presentations. He collaborates broadly with scientists in academia and the biotechnology industry and has been a mem­ber of many academic/governmental/industrial organisations and scientific advisory boards. He most recently served as an adjunct professor at Hong Kong Polytechnic University and currently sits on the board of managers of Ischemia Care Diagnostics LLC

Following a Phd in Pharmaceutical science and a Master in Cosmetology at the University of LYON in 1997, Dr. Florence Roullet started her carrier building a 10 years international experience into formulation and regulatory affairs in cosmet­ics; first during her years at the R and D center of BDF in Germany, then at the Make up subcontractor Gamma Croma in Italy as Technical Director. Additionally, taking the opportunity of returning to France in 2007, Florence joined the newly created structure of the FAREVA group dedicated to make up: FAREVACOLOR, where I took the position of R and D director until beginning of 2010. Florence joined then APTAR to take in charge the newly created position of Beauty Skin care and make up laboratory director; finally, last May 2018, Florence was as­signed a new position within APTAR as Beauty Formulations and Materials Direc­tor; from innovations to existing range, with her team she studies how materials and complete packaging’s made thereof, can be a source of interactions and/or synergies with customer formulations, for the application fields of Skin Care, Male Up and Fragrances.

Dr. Annette Mehling has been working for BASF Personal Care and Nutrition GmbH (and Cognis GmbH) since 2001. In her current position within the global product performance and claims group, her main areas of responsi­bility include dermatological compatibility and efficacy testing. Dr. Mehling is a trained molecular biologist and obtained her PhD in microbiology from the University of Wuppertal, Germany. During her postdoctoral training at the Department of Dermatology at the University of Münster, Germany, she was involved in research in the field of cutaneous immunology. She later obtained a degree in toxicology at the University of Leipzig and is a Eurotox-registered toxicologist. Over the years she has been an active member of multidisciplinary national and international working groups and has chaired or cochaired a number of working groups. She currently cochairs the skin sensitization working group at the European Partnership for Alternative Ap­proaches to Animal Testing (EPAA). She has authored numerous papers, e.g. in the areas of alternatives to animal testing, compatibility of surfactants, chronobiology and sensitive skin.

Nathalie Calvel is a biological engineer (“Institut National des Sciences Appli­quées-INSA” of Toulouse, France). She began her career as a study engineer then as a technical regulatory affairs engineer (food and environmental regu­lations) at Lesaffre international. Nathalie joined Pierre Fabre pharmaceutical Group in 2006. She was in charge of developing a R&D database on plants and plant-based active ingredients. Since 2011, she has been working as a Project Manager in charge of Botanical Expertise Pierre Fabre, a process for the devel­opment of plant-based active ingredients from the research on plants and their key components to their culture, their extraction and the use of their extracts in the product formulas. Since 2016, she has been a member of the collective action of PASS French competitive cluster on sustainable supply chains. This action aimed to develop tools needed to evaluate and optimize the environ­mental and social performance of ingredients. If the turning point of sustain­able chemistry and responsible production are obvious, performance indicators must be defined. The complexity of the production chain makes this issue even more complex when it comes to plant extracts or raw materials from the living. Defined by 11 expert companies and the PASS cluster, sharing the values of respect for the man, for the environment and for the biodiversity throughout the production chain, the ERI 360°- Eco Responsible Ingredient label offers concrete answers to this crucial question. Since 2019 she’s a sustainable supply chain quality manager as part of Green Mission Pierre Fabre, an environmentally friendly commitment of Pierre Fabre Group to maximize its green and sustain­able innovation and to make its activities greener and meaningful, based on 5 objectives: innovate, protect, respect, guarantee, engage.

Tom Verlinden obtained a master’s in pharmaceutical science (University of Antwerp) and a master’s in industrial pharmacy (IPIL, France). Tom sub­stantiated his knowledge at the EM Lyon business school and proceeded to work in a mid-sized pharmaceutical company (COO at Gifrer de SEV, France). Tom has experience with leadership as he has spent many years in manage­ment positions (VP and COO) at Qualiphar (Belgium) and (VP and responsible pharmacist) at Gifrer SAS (France).

Unilever is a leader in microbiome research through a global network of internal research, high profile external collaborations and a significant invest­ment in the MIF-OMICS capability in the UK. Through this work, Unilever is developed significant understanding of the skin microbiome and in the consumer and cosmetic context and the development of microbiome product innovations. Michael Hoptroff is a senior R&D manager at Unilever with over 21 years of experience in advancing the science of skin microbiology and the skin microbiome and the development of personal care products. In this time he has worked within Unilever and with a range of industrial and academic partners on projects ranging from handwashing to scalp care to body as well as being active in oral microbiology research.

Dirk Petersohn studied biology and conducted his PhD-studies at the University of Cologne on the topic of tissue specific gene regulation in the human nervous system. After his postdoc studies on wound healing mechanisms in the team of Prof. Dr. Thomas Krieg, he joined Henkel in 1998. Since then he held various positions in research and development and is currently the director of Henkel’s department “Biophysics & Biological Research”. Additionally, he vice-chairs at Cosmetics Europe the steering committee “Science” and chairs the Task Force Skin Tolerance that is developing approaches to assess skin sensitization of chemicals without the use of animals.

Dr. Andreas Schepky received his PhD in biochemistry from the University of Hannover, Germany, in 1995, and his master’s in applied toxicology from the University of Surrey, United Kingdom, in 2016. He has been a UK and Eurotox Registered Toxicologist since 2018. Since 2007, he has been heading the glob­al toxicology department of Beiersdorf AG in Hamburg, Germany, focussing on the development of alternative methods in the fields of skin bioavailability and sensitisation, mutagenicity, irritation and ADME. He has been the chair of Cos­metic Europe’s task force on skin bioavailability/ADME since 2013. Andreas is a full member of the SOT, the British Toxicology Society, the European Society of Toxicology in vitro as well as of the German Society of Pharmacology and Toxicology. He joined Beiersdorf in 1995, starting as head of the biochemistry laboratory of skin.

Alain owns a MSc. in Biochemistry / Physico-chemistry and a Ph.D degree from Dermatology Unit at University Hospital, Besancon, FR. Prior to join Oriflame, Alain worked for 12 years at Pierre Fabre Dermo-Cosmétique, Toulouse, in skin delivery/metabolism & new active ingredients discovery. In 2009, Alain joined Oriflame, and now is heading “Skin Research Institute, Open Innovation and Clinical Evaluation & Scientific Communication” Units. The team focus is to iden­tify global skin health needs, then design and develop innovative plant-based actives technologies, including consumer friendly product’s communication. With almost 25 years of expertise in Cosmetic research, about 60 scientific publications and several patents, Alain is passionate about skin aging, how to improve skin health and to enhance Beauty, by exploring the latest scientific and technology innovations and further translate them into consumers solutions. If further interested in Oriflame Research & Products, follows Alain’s Instagram account, @alainmavon.

Patrick Gonry graduated as a chemical engineer at the University of Ghent (Belgium) in 1991. Afterwards, he finished an intensive specialisation in cos­metic manufacturing and obtained a degree in dermato-cosmetic science at the Medical University of Brussels. He gained practical experience in the pro­duction and distribution of ingredients, also through his first company GOVA, which he founded in 1999. In 2001, he also started the consultancy company S&C, supporting cosmetic producers and raw material suppliers in product development, global legislation and toxicology. He trained many cosmetic chemists and technical sales representatives. Since 2002 his research has been dedicated to the skin microbiota, which resulted into the first prebiotic ingredient dedicated to baby care and intimate hygiene. He is the driving force behind many skin microbiota cosmetics in Europe. Through his latest company, Gobiotics, he offers the industry scientific solutions to support skin microbiota claims. Patrick is a determined scientist with concrete solutions and a heart for the invisible world on our skin.

Owner and Founder of Angel Consulting SAS, Cosmetologist Chemist

Invited Professor of Cosmetology at the University of Siena, Rome-Tor Vergata, Genoa, Tel Aviv. Member of European Responsible Person Association - ERPA- Bruxelles. Speaker at international seminars and training courses on International Cosmetic Regulations, Safety Assessment, Claim Substantiation, GMP Involved in a training course organized by Cosmetica Italia Servizi on Safety Assessment, GMP, Claim Substantiation. Partner of EU projects on development of new cosmetic technologies and new in silico tools under frame programs H2020 and Life (in past FP7)

Author of Chapter 2.2, Harry’s Cosmeticology: An Overview of the Changing Regulatory Landscape in the U.S and the E.U. and how to Deal with them.

Dr. Helena Eixarch is a cosmetics project manager providing regulatory support to clients. She is responsible for product label reviews, collation of product in­formation files (PIFs), preparation of cosmetic product safety reports (CPSRs), assisting responsible persons (RP) with their associated duties and advising on all aspects of regulatory compliance. Helena has gained extensive experience of the cosmetics industry working as a regulatory toxicologist for a major retailer in Spain, where she was in charge of ensuring product compliance with the requirements outlined in the EU Cosmetics Regulation. Helena has a degree and a PhD in biochemistry. She holds a diploma on cosmetic products safety assess­ment and a European Registered Toxicologist status.

Dr. Elisabeth Salom L’Ancien has been working in Beauty Industry for more than 20 years. After 10 years as Key Account Management, she took the position of VP Business Development at Aptar for fragrance dispensing, and Marketing Director for EMEA. Elisabeth has been exploring for several years on consumer’s fragrance gestures around the world, why and how consumers from all continents apply fragrance. This knowledge fuels an innovation plan around a vision = there are 1000 ways of applying fragrance, and the ultimate target is to re-enchant fragrance experience.

After obtaining an MSc in Biochemistry at the University of Pretoria, Jonathan moved into the fascinating world of formulating. He has worked for contract manufacturers based in South Africa and the UK, as well as Avon’s South African skincare brand. He has since worked in global cosmetic regulations for Heath­cote & Ivory, Burberry, and now Charlotte Tilbury where he oversees techni­cal development of new products, compliance with international regulations, product registrations, and regulatory implications of moving into new markets.

Dr. Matthias Kunze holds the position as a technical marketing manager for per­sonal care at LANXESS. Following studies in Kiel and Marburg, Germany, he obtained a PhD in chemistry in 2000. During five years with Dow Corning, Mat­thias was in charge of application development and customer management. At Clariant, he took the position as a key account manager, also being responsible for application development of preservatives and rheology modifiers. He joined LANXESS in 2012.

Natascia Grimaldi has received her PhD in Nanomaterial for Advanced Medicine from the University of Palermo (Italy) and the University of Maryland (USA) in 2014. From 2015, she has been working for the spin-off company Nanomol Tech­nologies SA (Spain), as Marie Curie Fellow first and as Junior Project Manager and Research group Frontman, lately. In 2018, she has joined Infinitec Activities (Spain) as R&D Liaison.